| Echocardiography to individualize treatment for hypertrophic cardiomyopathy. | |
| | |
MedLine Citation:
|
PMID: 22687587 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Treatments for hypertrophic cardiomyopathy are largely selected based on patient symptoms and echocardiographic findings. Moreover, all the advanced treatments for heart failure symptoms depend on such imaging for planning and monitoring response to therapy. Risk of sudden death correlates with maximum left ventricular (LV) wall thickness. Massive LV thickening of 30 mm or more is an indication for primary prevention of sudden death with an implanted defibrillator. In this review, we will underscore potential pitfalls in echocardiographic diagnosis. Also we will review, a newly appreciated pathophysiologic mechanism in obstruction dynamic systolic dysfunction due to gradient. |
| | |
Authors:
|
Mark V Sherrid; Milla Arabadjian |
Related Documents
:
|
22805997 - Normal values of left and right ventricular function measured by m-mode, pulsed doppler... 983957 - Coronary arterial reperfusion. iii. early and late effects on regional myocardial funct... 22885457 - Cardiac biointerventions: whatever happened to stem cell and gene therapy? 7127357 - Extension of myocardial necrosis into normal epicardium followng hypotension during exp... 2003147 - Isolated pulmonary valvular regurgitation: current perspectives. 8144787 - Quantitation of absolute regional myocardial perfusion using cine computed tomography. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Progress in cardiovascular diseases Volume: 54 ISSN: 1873-1740 ISO Abbreviation: Prog Cardiovasc Dis Publication Date: 2012 May-Jun |
Date Detail:
|
Created Date: 2012-06-12 Completed Date: 2012-09-04 Revised Date: 2013-05-02 |
Medline Journal Info:
|
Nlm Unique ID: 0376442 Medline TA: Prog Cardiovasc Dis Country: United States |
Other Details:
|
Languages: eng Pagination: 461-76 Citation Subset: AIM; IM |
Copyright Information:
|
Copyright © 2012. Published by Elsevier Inc. |
Affiliation:
|
Division of Cardiology, St Luke's-Roosevelt Hospital Center, Columbia University, College of Physicians and Surgeons, 1000 10th Ave, New York City, NY 10019, USA. msherrid@chpnet.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cardiac Resynchronization Therapy
/
methods* Cardiac Surgical Procedures / methods* Cardiomyopathy, Hypertrophic / therapy*, ultrasonography Cardiovascular Agents / therapeutic use* Diagnosis, Differential Echocardiography* Humans Monitoring, Physiologic / methods* Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Cardiovascular Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Genetic considerations in hypertrophic cardiomyopathy.
Next Document: Stress testing in patients with hypertrophic cardiomyopathy.